4.490SEK-0.99%Mkt Cap: 698.82M SEKP/E: —Last update: 2026-05-13
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The compa…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-14.82
PEG—
P/B2.29
P/S6.74
EV/EBITDA-5.63
EV/Revenue6.41
EPS (TTM)-0.80
EPS (Forward)-0.30
Cash Flow & Leverage
FCF Yield-9.38%
FCF Margin-63.15%
Operating CF-109.10M SEK
CapEx (TTM)18.10M SEK
Net Debt/EBITDA0.28
Net Debt-33.56M SEK
Technical
SMA 504.584 (-2.0%)
SMA 2005.327 (-15.7%)
Beta0.38
S&P 52W Chg24.23%
Avg Vol (30d)293.90K
Avg Vol (10d)222.27K
Technical Indicators
RSI (14)44.2
MACD-0.0400
MACD Signal0.0056
MACD Hist.-0.0456
BB Upper5.706 SEK
BB Middle4.869 SEK
BB Lower4.032 SEK
BB Width34.38%
ATR (14)0.2971 SEK
Vol Ratio (20d)0.35x
52W Range
3.85018% of range7.380
52W High7.380 SEK
52W Low3.850 SEK
Profitability
Gross Margin33.35%
EBITDA Margin-113.87%
Profit Margin-132.11%
Oper. Margin-111.42%
ROE-45.14%
ROA-37.03%
Revenue Growth-1.10%
Earnings Growth—
Balance Sheet
Debt/Equity0.05
Current Ratio3.76
Quick Ratio2.67
Book Value/Sh1.937 SEK
Cash/Share0.3520 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.157.22M
Float111.73M
Insiders47.08%
Institutions18.78%
Analyst Consensus
Rating—
Target (Mean)9.500 SEK
Target Range9.500 SEK – 9.500 SEK
# Analysts1
Company
Market Cap698.82M SEK
Enterprise Value665.26M SEK
Revenue (TTM)103.76M SEK
Gross Profit34.69M SEK
Net Income (TTM)-137.42M SEK
Revenue/Share0.6780 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees59
Last Price4.490 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—